Purdue Pharma reaches settlement with feds: Baton Rouge case still in the works

    Purdue Pharma, the maker of OxyContin, has reached a $8.34 billion settlement with the U.S. Justice Department and agreed to plead guilty to three felonies over its role in the nation’s opioid crisi…


    Already an INSIDER? Sign in.